Voranigo
Payments companies reported to CMS as associated with Voranigo. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Voranigo, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Voranigo
These are the largest totals companies reported as associated with Voranigo. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Rimas Lukas | Chicago, IL | Hematology & Oncology | $56,123.35 |
| Suriya Jeyapalan | Boston, MA | Neurology (Psychiatry & Neurology) | $40,141.40 |
| Jennifer Serventi | Rochester, NY | Physician Assistant | $36,205.86 |
| Jethro Hu | West Hollywood, CA | Neurology (Psychiatry & Neurology) | $30,410.62 |
| Tresa Mcgranahan | Encinitas, CA | Neurology (Psychiatry & Neurology) | $29,850.47 |
| Elizabeth Neil | Minneapolis, MN | Neurology (Psychiatry & Neurology) | $22,187.47 |
| Vinai Gondi | Warrenville, IL | Radiation Oncology | $22,148.67 |
| Steven Chmura | Chicago, IL | Radiation Oncology | $21,185.05 |
| Robert Chong | Los Angeles, CA | Neurology (Psychiatry & Neurology) | $19,107.37 |
| Mitchel Berger | San Francisco, CA | Neurological Surgery | $18,387.81 |
Prescribed Voranigo?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.